| MolName | (2R,4S)-2-[[4-(2-amino-2-oxoethoxy)phenyl]methyl]-5-[(3S,5R)-3,5-dibenzyl-2-oxopyrrolidin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]pentanamide |
| MolecularFormula | C41H45N3O6 |
| Smiles | NC(COc1ccc(C[C@H](C[C@@H](CN([C@@H](Cc2ccccc2)C[C@@H]2Cc3ccccc3)C2=O)O)C(N[C@H]([C@@H](C2)O)c3c2cccc3)=O)cc1)=O |
| InChI | InChI=1S/C41H45N3O6/c42-38(47)26-50-35-17-15-29(16-18-35)19-31(40(48)43-39-36-14-8-7-13-30(36)24-37(39)46)23-34(45)25-44-33(21-28-11-5-2-6-12-28)22-32(41(44)49)20-27-9-3-1-4-10-27/h1-18,31-34,37,39,45-46H,19-26H2,(H2,42,47)(H,43,48)/t31-,32+,33-,34+,37-,3 |
| InChIK | POMSJFYOYXHCEK-PDKOWJCBSA-N |
| TotalMolweight | 675.823 |
| Molweight | 675.823 |
| MonoisotopicMass | 675.330837 |
| CLogP | 4.5666 |
| CLogS | -5.939 |
| H Acceptors | 9 |
| H Donors | 4 |
| TotalSurfaceArea | 516.85 |
| Relative PSA | 0.20431 |
| PolarSurfaceArea | 142.19 |
| Druglikeness | 5.9368 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.42 |
| Fragments | 1 |
| Non HAtoms | 50 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| StereoCenters | 6 |
| Rotatable Bond | 15 |
| Rings Closures | 6 |
| Small Rings | 6 |
| Aromatic Rings | 4 |
| Aromatic Atoms | 24 |
| Sp3Atoms | 17 |
| Symmetricatoms | 6 |
| Amides | 3 |
| StereoCon | this enantiomer |
Click to Load Molecule:
1 - (2R,4S)-2-[[4-(2-amino-2-oxoethoxy)phenyl]methyl]-5-[(3S,5R)-3,5-dibenzyl-2-oxopyrrolidin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]pentanamide | 2 - (2R,4S)-2-[[4-(2-amino-2-oxoethoxy)phenyl]methyl]-5-[(3S,5R)-3,5-dibenzyl-2-oxopyrrolidin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]pentanamide